In his first term, President Trump pledged to boost HIV spending, with the lofty goal of bringing the epidemic to heel by ...

Two partnerships will provide millions of people access to what is widely described as the most effective HIV prevention drug ...

The CDC made a strong recommendation based on a high certainty of evidence to use the long-acting injectable lenacapavir ...

Infectious disease experts have hailed a move that will see a highly effective HIV prevention drug be sold at just 40 dollars ...

A twice-yearly injection described as the most promising HIV prevention tool in decades is poised to reach millions more people, with new generic versions priced at about $40 per patient per year.

Research published in The Lancet HIV earlier this year, experts estimated that, if purchased at scale, the cost of generic lenacapavir could range from USD 35 to USD 46 per person-year. Falling to USD ...

To reduce the spread of sexually transmitted diseases, the U.S. Centers for Disease Control and Prevention has proposed recommending a common antibiotic be taken after having unprotected sex. Under ...

Lots of scholarship assumes that partners in higher-quality relationships work together to reduce health-related risks. A new study tested this assumption.

Indian drugmakers Dr Reddy's Laboratories and Hetero Labs said on Wednesday that they will sell generic versions of a new and ...

By the end of 2024, Bangladesh had registered 12,422 cumulative HIV cases, of which 2,281 had died. Health experts estimate that around 16,863 people are currently living with HIV in the country.